New VolparaDensity software update obtains FDA approval

By Staff News Brief

Volpara Solutions of Wellington, New Zealand, has received U.S. Food and Drug Administration 510(k) clearance for an update to its VolparaDensity™ breast density assessment software. The software update more accurately reflects breast density from images captured using the Hologic SmartCurve™ system.

VolparaDensity, available as a feature of VolparaEnterprise™ software, produces automated, objective volumetric assessments of breast density. It also assigns tissue a breast density category that correlates to BI-RADS categories.

Back To Top

New VolparaDensity software update obtains FDA approval.  Appl Radiol. 

By Staff News Brief| February 07, 2019

About the Author

Staff News Brief

Staff News Brief

Copyright © Anderson Publishing 2019